CN101863943B - Crystallizing method of 5'-guanosine-monophosphate disodium salt - Google Patents

Crystallizing method of 5'-guanosine-monophosphate disodium salt Download PDF

Info

Publication number
CN101863943B
CN101863943B CN201010210408.3A CN201010210408A CN101863943B CN 101863943 B CN101863943 B CN 101863943B CN 201010210408 A CN201010210408 A CN 201010210408A CN 101863943 B CN101863943 B CN 101863943B
Authority
CN
China
Prior art keywords
gmp
guanosine
disodium salt
crystal
monophosphate disodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201010210408.3A
Other languages
Chinese (zh)
Other versions
CN101863943A (en
Inventor
陈玉松
陈玉平
孙明贤
李威
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DALIAN ZHEN-AO BIO-ENGINEERING STOCK Co Ltd
Original Assignee
DALIAN ZHEN-AO BIO-ENGINEERING STOCK Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DALIAN ZHEN-AO BIO-ENGINEERING STOCK Co Ltd filed Critical DALIAN ZHEN-AO BIO-ENGINEERING STOCK Co Ltd
Priority to CN201010210408.3A priority Critical patent/CN101863943B/en
Publication of CN101863943A publication Critical patent/CN101863943A/en
Application granted granted Critical
Publication of CN101863943B publication Critical patent/CN101863943B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Saccharide Compounds (AREA)

Abstract

The invention discloses a crystallizing method of a 5'-guanosine-monophosphate disodium salt, which has the advantages of simple operation as well as large crystalline particle, uniform particle, attractive fineness and high purity of products. The method comprises the following steps of: adding sodium hydroxide to a 5'-GMP aqueous solution of which the concentration is 5-40 percent; regulating the PH value of the solution to 7-11 and then adding absolute alcohol which has a PH value of 7-11 and is 0.5-3 times of the solution in volume and a catalyst; stirring at 15-80 DEG C to separate out 5'-GMP, 2Na; and centrifuging, washing and drying to obtain 5'-GMP, 2Na crystals, wherein the catalyst is a mixture of a 60-120 mesh siftage of 5'-guanosine-monophosphate disodium salt crystals and sodium carbonate, the mass ratio of the 60-120 mesh siftage of 5'-guanosine-monophosphate disodium salt crystals to the sodium carbonate is 1:2, and the addition quantity of the catalyst is 0.1-0.2 percent of the mass of the 5'-GMP.

Description

The crystallization method of 5'-GMP,2Na
Technical field:
The present invention relates to a kind of crystallization purifying method, especially a kind of simple to operate, product crystallization is large, the crystallization method of good fluidity, uniform particles, quality is attractive in appearance, purity is high 5'-GMP,2Na.
Background technology:
5 '-Nucleotide (CMP, AMP, UMP, GMP, IMP) be the product that RNA obtains through enzymic degradation, be widely used in just stipulating to add 5 '-Nucleotide in the international infant formula industry standards of field ,Ru such as medicine, chemical industry, food, healthcare products and agricultural, and the purity of 5 '-Nucleotide is an industrial difficult problem always.
At present, the method for purification of known 5'-GMP,2Na (5 '-GMP, 2Na) is conventional crystallization method, i.e. ethanol dissolved method.Be first with sodium hydroxide, to regulate 5 '-cyclic guanosine monophosphate solution of finite concentration, temperature, make it be alkalescence, and then add alcohol solvent to stir, make 5 '-GMP, 2Na separates out, and through centrifugal, washing and dry, obtains 5 '-GMP, 2Na crystal.Because alcohol solvent makes 5 '-GMP in solution, 2Na solubleness reduces, and causes 5 '-GMP, and the violent outburst of 2Na is separated out, and the product of separating out are white powder or the small-crystalline that viscosity is high, solid-liquid centrifugation difficulty.Products obtained therefrom exist particle inequality and water absorbability strong, the difficulty of sieving of easily uniting, the problem such as low and poor fluidity of purity.
Summary of the invention:
The present invention is the above-mentioned technical problem existing in order to solve prior art, provides a kind of simple to operate, and product crystallization is large, the crystallization method of good fluidity, uniform particles, quality is attractive in appearance, purity is high 5'-GMP,2Na.
Technical solution of the present invention is: a kind of crystallization method of 5'-GMP,2Na, it is characterized in that carrying out as follows: in the 5 '-GMP aqueous solution that is 5%~40% in concentration, add sodium hydroxide, adjusting solution pH value is 7~11, the dehydrated alcohol and the catalyzer that add 0.5~3 times of PH7~11 liquor capacity, be to stir under the condition of 15~80 ℃ in temperature again, makes 5 '-GMP, 2Na separates out, through centrifugal, washing and dry, obtain 5 '-GMP, 2Na crystal; Described catalyzer is the mixture of 5'-GMP,2Na crystal 60~120 order screen underflows and sodium carbonate, the mass ratio of 5'-GMP,2Na crystal 60~120 order screen underflows and sodium carbonate is 1: 2, and the addition of catalyzer is 1 of 5 '-GMP quality~2 ‰.
The present invention is in solution, to have added the catalyzer consisting of 5'-GMP,2Na crystal 60~120 order screen underflows and sodium carbonate with the maximum difference of prior art, improved ethanol to 5 '-GMP, the solubleness of 2Na, avoid 5 '-GMP, existing problem is separated out in the violent outburst of 2Na, gained 5 '-GMP, 2Na crystal is particulate state white macrocrystal, viscosity is low, solid-liquid separation is easy, product appearance is bright, uniform particles, good fluidity, be difficult for moisture absorption, can prevent the difficulty of sieving of uniting and existing because of moisture absorption, products obtained therefrom purity is high, through liquid chromatographic detection purity, be 98~102%, can be applicable to suitability for industrialized production
Embodiment:
Getting concentration is 5 '-guanosine monophosphate aqueous solution 1000L of 180g/L, with sodium hydroxide, is adjusted to PH7.5, then adds 2000L dehydrated alcohol and catalyzer, at 35 ℃, stirs, and makes 5 '-GMP, and 2Na separates out.Described catalyzer is the mixture of 5'-GMP,2Na crystal 60~120 order screen underflows and sodium carbonate, the mass ratio of 5'-GMP,2Na crystal 60~120 order screen underflows and sodium carbonate is 1: 2, and the addition of catalyzer is 1 of 5 '-GMP quality~2 ‰.Precipitate, after centrifugal solid-liquid separation, again with the white crystal of 85% washing with alcohol gained, dry, can obtain 5'-GMP sodium salt crystal 193.0kg.With liquid chromatograph, check that finished product purity is 99.4%, moisture 17%, last crystallization yield is 90%.
Detected result is as table 1:
Table 1
Test item Standard Embodiment of the present invention product
Outward appearance Should be white or off-white color crystallographic powder White crystal
HPLC measures purity 97%~102% 99.4%
Moisture (%) 15%~25% 17.0%
A250/260(PH7.0) 1.13~1.19 1.17
A280/260(PH7.0) 0.64~0.68 0.66
PH 7.0~8.5 8.1
Density (g/cm 3) International standard is more than 0.45 0.65
Mobility (seeing explanation 1) Be less than three beatings Without patting
Transmittance More than 95% 97%
See through order number 60 order~120 orders 60~80 orders account for more than 95%
Illustrate 1: whether mobility needs to pat is judging criterion, be about to 5 '-GMP, 2Na fills the husky clock first half, then rely on gravity to make 5 '-GMP, 2Na flows vertically downward, in defluent process, need not pat husky clock is that mobility is best, and it is good patting (1-3 time) for few time, and repeatedly (more than 3 times) are that mobility is bad.

Claims (1)

1. the crystallization method of a 5'-GMP,2Na, it is characterized in that carrying out as follows: in the 5 '-GMP aqueous solution that is 5%~40% in concentration, add sodium hydroxide, adjusting pH is 7~11, the dehydrated alcohol and the catalyzer that add 0.5~3 times of pH7~11 liquor capacity, be to stir under the condition of 15~80 ℃ in temperature again, makes 5 '-GMP, 2Na separates out, through centrifugal, washing and dry, obtain 5 '-GMP, 2Na crystal; Described catalyzer is the mixture of 5'-GMP,2Na crystal 60~120 order screen underflows and sodium carbonate, the mass ratio of 5'-GMP,2Na crystal 60~120 order screen underflows and sodium carbonate is 1: 2, and the addition of catalyzer is 1 of 5 '-GMP quality~2 ‰.
CN201010210408.3A 2010-06-28 2010-06-28 Crystallizing method of 5'-guanosine-monophosphate disodium salt Active CN101863943B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201010210408.3A CN101863943B (en) 2010-06-28 2010-06-28 Crystallizing method of 5'-guanosine-monophosphate disodium salt

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201010210408.3A CN101863943B (en) 2010-06-28 2010-06-28 Crystallizing method of 5'-guanosine-monophosphate disodium salt

Publications (2)

Publication Number Publication Date
CN101863943A CN101863943A (en) 2010-10-20
CN101863943B true CN101863943B (en) 2014-03-12

Family

ID=42955898

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201010210408.3A Active CN101863943B (en) 2010-06-28 2010-06-28 Crystallizing method of 5'-guanosine-monophosphate disodium salt

Country Status (1)

Country Link
CN (1) CN101863943B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103570783B (en) * 2013-11-19 2016-08-17 南京工业大学 A kind of Sodium guanylate turns brilliant method
KR102284843B1 (en) * 2019-10-08 2021-08-02 씨제이제일제당 주식회사 Method of producing 5'-guanylic acid disodium 7 hydrate crystals
KR102282384B1 (en) 2019-11-20 2021-07-27 씨제이제일제당 주식회사 Purification method of nucleic acid

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1861624A (en) * 2006-06-12 2006-11-15 南京工业大学 Crystallization process of 5'-nucleoside-sodium phosphate
CN101619089A (en) * 2009-07-28 2010-01-06 陈大刚 Anticancer drug CL168, synthesis method and application thereof
CN101654469A (en) * 2009-09-04 2010-02-24 华南理工大学 5'-guanosine-disodium phosphate crystallizing method

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1861624A (en) * 2006-06-12 2006-11-15 南京工业大学 Crystallization process of 5'-nucleoside-sodium phosphate
CN101619089A (en) * 2009-07-28 2010-01-06 陈大刚 Anticancer drug CL168, synthesis method and application thereof
CN101654469A (en) * 2009-09-04 2010-02-24 华南理工大学 5'-guanosine-disodium phosphate crystallizing method

Also Published As

Publication number Publication date
CN101863943A (en) 2010-10-20

Similar Documents

Publication Publication Date Title
CN103108881A (en) Derivatization of oligosaccharides
CN101863943B (en) Crystallizing method of 5'-guanosine-monophosphate disodium salt
CN107836723B (en) Prebiotics additive and preparation method and application thereof
WO2019119339A1 (en) Copper oxychloride particulate matter and preparation method therefor
CN104402023B (en) A kind of production method improving carbonizatin method sodium bicarbonate product granularity
CN102503800A (en) Refining method of C11-C18 long-chain diacid
JP2016216447A (en) Manufacturing method of anhydrous sodium acetate crystal and anhydrous sodium acetate crystal
EP2613778B1 (en) Process for the production of l-carnitine tartrate
US20230133446A1 (en) Methods for providing a solid hmo product, and solid hmo products obtained thereby
CN107712345B (en) Nucleotide mixture crystal powder and preparation method thereof
CA2861891A1 (en) Crystal form of (6s)-5-methyltetrahydrofolate salt and method for preparing same
CN104961740B (en) A kind of solid preparation containing riboflavin and preparation method thereof
CN104592053B (en) A kind of industrialized process for preparing of high-purity sodium pantothenate
CN102241599B (en) Method for preparing glycine
CN100484526C (en) Compounding method of cefpirome sulfate raw material and uses thereof
JP2007191413A (en) Pure glucosamine and method for producing the same
AU2018230564A1 (en) Process for crystallizing 2'-fucosyllactose and related compositions
CN106432021B (en) A kind of preparation method of Fudosteine crystallization
CN111116610B (en) Production method of cefoperazone sodium
CN105543202B (en) Method for improving bioactivity of L-aspartate alpha-decarboxylase
CN103937866A (en) Improved preparation method of ampicillin
CN104151154B (en) A kind of production method of citric acid monohydrate crystal
CN111675610B (en) Refining method for preparing high-purity non-caking fine-particle citric acid crystals
CN109535022B (en) Preparation method for improving fluidity of L-carnitine fumarate
CN104277044A (en) Method for efficiently preparing low-calcium-content folinic acid

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant